Literature DB >> 8123237

Oxygen tension measurements of head and neck cancers.

D J Terris1, E P Dunphy.   

Abstract

OBJECTIVE: There is continued investigation of agents capable of overcoming hypoxic cell radioresistance. The evaluation of tumor oxygenation, therefore, assumes great importance. Previous efforts to measure tumor oxygen tension (PO2) using polarographic methods were limited by the size of the electrodes and efficiency of measurements. A new system employing fine-needle electrodes and a computerized micromanipulator was evaluated.
DESIGN: Prospective study. PATIENTS: Sixteen patients with cancers of the head and neck, seen at Stanford (Calif) University Medical Center and Santa Clara Valley Medical Center, San Jose, Calif, between March 1, 1991, and July 31, 1991. Of the 16 tumors, 14 were squamous cell carcinomas; 11 were previously untreated. In two patients, measurements were repeated during radiation therapy. In three patients, measurements were taken under conditions of varied inspired oxygen during anesthesia. In seven patients, subcutaneous tissue (SQ) measurements were made for comparison.
RESULTS: The mean (+/- SD) PO2 of all tumors was 25.6 +/- 20.2 mm Hg, with a range of 2.3 to 76.4 mm Hg. When only squamous cell carcinomas were considered, the mean tumor PO2 was 22.7 +/- 16.0 mm Hg. The mean SQ measurement was 57.2 +/- 12.8 mm Hg. In all cases (seven of seven) in which SQ data were available, the tumor PO2 was lower than the SQ PO2 by an average of 41.8 mm Hg. The mean tumor PO2 increased in two of three cases of hyperoxia and decreased in the the third. The mean tumor PO2 increased in one patient after 25 Gy of radiotherapy and remained the same in the other.
CONCLUSIONS: These measurements suggest that there is significant interindividual variability in the PO2 of head and neck cancers. Squamous cell cancers are generally less well oxygenated than normal SQ tissue. The PO2 histograph identified patients with a low mean tumor PO2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8123237     DOI: 10.1001/archotol.1994.01880270031006

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  10 in total

1.  DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.

Authors:  M J Dorie; M S Kovacs; E C Gabalski; M Adam; Q T Le; D A Bloch; H A Pinto; D J Terris; J M Brown
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Phosphorescent nanoparticles for quantitative measurements of oxygen profiles in vitro and in vivo.

Authors:  Nak Won Choi; Scott S Verbridge; Rebecca M Williams; Jin Chen; Ju-Young Kim; Russel Schmehl; Cornelia E Farnum; Warren R Zipfel; Claudia Fischbach; Abraham D Stroock
Journal:  Biomaterials       Date:  2012-01-10       Impact factor: 12.479

3.  Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside.

Authors:  R C Urtasun; M B Parliament; A J McEwan; J R Mercer; R H Mannan; L I Wiebe; C Morin; J D Chapman
Journal:  Br J Cancer Suppl       Date:  1996-07

4.  In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements.

Authors:  J M Star-Lack; E Adalsteinsson; M F Adam; D J Terris; H A Pinto; J M Brown; D M Spielman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

5.  Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma.

Authors:  Fangyao Hu; Karthik Vishwanath; H Wolfgang Beumer; Liana Puscas; Hamid R Afshari; Ramon M Esclamado; Richard Scher; Samuel Fisher; Justin Lo; Christine Mulvey; Nirmala Ramanujam; Walter T Lee
Journal:  Oral Oncol       Date:  2014-07-16       Impact factor: 5.337

6.  The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

Authors:  Christina S Kong; Balasubramanian Narasimhan; Hongbin Cao; Shirley Kwok; Julianna P Erickson; Albert Koong; Nader Pourmand; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-01       Impact factor: 7.038

Review 7.  Blood flow and oxygenation status of human tumors. Clinical investigations.

Authors:  H J Feldmann; M Molls; P Vaupel
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

8.  Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy.

Authors:  H Yoshikawa; E J Ehrhart; J B Charles; J T Custis; S M LaRue
Journal:  Vet Comp Oncol       Date:  2013-07-02       Impact factor: 2.613

9.  In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma.

Authors:  Quynh-Thu Le; Albert Koong; Yee Yie Lieskovsky; Balasubramanian Narasimhan; Edward Graves; Harlan Pinto; J Martin Brown; Daniel Spielman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-06       Impact factor: 7.038

10.  PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.).

Authors:  Courtney Nicholas; Jennifer Yang; Sara B Peters; Matthew A Bill; Robert A Baiocchi; Fengting Yan; Saïd Sïf; Sookil Tae; Eugenio Gaudio; Xin Wu; Michael R Grever; Gregory S Young; Gregory B Lesinski
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.